Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.365
+0.025 (1.87%)
Jun 26, 2026, 2:08 PM EDT - Market open
Cibus Revenue
Cibus had revenue of $1.68M in the quarter ending March 31, 2026, with 62.57% growth. This brings the company's revenue in the last twelve months to $4.29M, down -9.79% year-over-year. In the year 2025, Cibus had annual revenue of $3.64M, down -14.62%.
Revenue (ttm)
$4.29M
Revenue Growth
-9.79%
P/S Ratio
24.22
Revenue / Employee
$36,322
Employees
118
Market Cap
104.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.64M | -623.00K | -14.62% |
| Dec 31, 2024 | 4.26M | 2.45M | 134.56% |
| Dec 31, 2023 | 1.82M | 1.66M | 1,057.32% |
| Dec 31, 2022 | 157.00K | -25.83M | -99.40% |
| Dec 31, 2021 | 25.99M | 2.14M | 8.96% |
| Dec 31, 2020 | 23.85M | 16.56M | 226.91% |
| Dec 31, 2019 | 7.30M | 7.06M | 2,991.53% |
| Dec 31, 2018 | 236.00K | -272.00K | -53.54% |
| Dec 31, 2017 | 508.00K | 109.00K | 27.32% |
| Dec 31, 2016 | 399.00K | -873.00K | -68.63% |
| Dec 31, 2015 | 1.27M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Black Diamond Therapeutics | 70.00M |
| Fortress Biotech | 66.16M |
| Verrica Pharmaceuticals | 37.16M |
| Cue Biopharma | 32.73M |
| Pelthos Therapeutics | 27.70M |
| Alps Group | 3.74M |
CBUS News
- 9 days ago - Cibus Transcript: Sidoti Small-Cap Virtual Investor Conference - Transcripts
- 9 days ago - Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus - GlobeNewsWire
- 17 days ago - Cibus names Craig Wichner as CEO - TheFly
- 17 days ago - Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation - GlobeNewsWire
- 24 days ago - Cibus Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Cibus files $200M mixed securities shelf - TheFly
- 6 weeks ago - Cibus Registration statement: Registration filing - Filings
- 6 weeks ago - Cibus Earnings Call Transcript: Q1 2026 - Transcripts